1 High-Flying Stock With More Upside Ahead
Over the past five years, Axsome Therapeutics (NASDAQ: AXSM) has been on fire. The company has crushed the market in this period on the back of solid clinical and regulatory progress. At this point, it's fair to ask whether there is any upside left for the company, which is on the verge of reaching large-cap status.
The good news is that there might just be. Let's discuss why it's not too late to invest in Axsome Therapeutics.
Image source: Getty Images.
Source Fool.com


